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Macrophage secretion of miR-106b-5p causes
renin-dependent hypertension
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Á Baldán 6, B. A. Benitez 7, M. L. Sequeira-Lopez8,9, R. A. Gomez8,9 & C. Bernal-Mizrachi 1,5,10✉
Myeloid cells are known mediators of hypertension, but their role in initiating renin-induced
hypertension has not been studied. Vitamin D deficiency causes pro-inflammatory macro-
phage infiltration in metabolic tissues and is linked to renin-mediated hypertension. We
tested the hypothesis that impaired vitamin D signaling in macrophages causes hypertension
using conditional knockout of the myeloid vitamin D receptor in mice (KODMAC). These
mice develop renin-dependent hypertension due to macrophage infiltration of the vasculature
and direct activation of renal juxtaglomerular (JG) cell renin production. Induction of endo-
plasmic reticulum stress in knockout macrophages increases miR-106b-5p secretion, which
stimulates JG cell renin production via repression of transcription factors E2f1 and Pde3b.
Moreover, in wild-type recipient mice of KODMAC/miR106b−/− bone marrow, knockout of
miR-106b-5p prevents the hypertension and JG cell renin production induced by KODMAC
macrophages, suggesting myeloid-specific, miR-106b-5p-dependent effects. These findings
confirm macrophage miR-106b-5p secretion from impaired vitamin D receptor signaling
causes inflammation-induced hypertension.
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Hypertension is the most common cardiovascular riskfactor and a major contributor to cardiovascular mor-bidity and mortality1. As the cellular and molecular
mechanisms of hypertension and inflammation are more clearly
defined, it is apparent that these processes are interrelated.
Overactivation of the renin–angiotensin system (RAS) creates a
cycle of pro-inflammatory macrophage accumulation and sti-
mulation of oxidative stress in the vasculature, resulting in nitric
oxide scavenging, low renal blood flow, and subsequently
increased renin secretion from the juxtaglomerular apparatus2.
Conversely, the absence of the monocyte lineage prevents
angiotensin II-induced hypertension in mice3. Transplantation of
wild-type (WT) bone marrow macrophages restores hypertensive
responses to angiotensin II in these mice, suggesting that innate
immune cells are necessary mediators in the development of
hypertension4. However, immune cells have never been shown to
directly initiate renin-induced hypertension. Observational stu-
dies link vitamin D deficiency to the development of hyperten-
sion5. Mendelian randomization analysis suggests a causal
association between increased 25-hydroxyvitamin D [25(OH)D]
concentrations and reduced blood pressure and hypertension
risk6. However, randomized controlled trials have yielded mixed
results, likely due to small study size, variable treatment regimens,
and inclusion of participants with normal vitamin D levels or
antihypertensive medications7. In mice, germline vitamin D
receptor (VDR) knockouts exhibit hypertension and cardiac
hypertrophy due to upregulation of renin promoter activity and
RAS activation8. The VDR is expressed in myeloid cells and B
and T lymphocytes9. VDR activation prevents IFNγ-, LPS-, and
CD40L-induced monocyte production of pro-inflammatory
cytokines known to induce vascular inflammation10–12. Vdr
deletion promotes a pro-inflammatory macrophage phenotype,
with increased adhesion and migration into the vasculature
causing atherosclerosis progression13,14. In this study, we show
that vitamin D-mediated ER stress and subsequent miR-106b-5p
secretion from macrophages is sufficient to cause hypertension.
Results
Myeloid-specific Vdr deletion induces hypertension. To begin
to determine the role of macrophages in the hypertensive phe-
notype resulting from vitamin D deficiency, we generated mye-
loid cells lacking VDR (KODMAC) by crossing Vdrfl/fl mice with
lysosome-M-promoter-driven Cre mice (Lyz2Cre) in the Ldlr−/−
background (a model of diet-induced metabolic syndrome), and
compared them to Vdrfl/flLdlr−/− littermates (control). At
8 weeks, chow-fed KODMAC mice showed increased mean
arterial blood pressure by 24-h telemetry in both genders
(Fig. 1a), with significant differences in both systolic and diastolic
blood pressure (SBP and DBP) that persisted for at least 1 year
(Supplementary Fig. 1a, b). KODMAC mice in the ApoE−/− or
C57BL6 backgrounds showed similar results (Supplementary
Fig. 1c, d). KODMAC mice also had 30% higher plasma renin
and lower urinary sodium (Fig. 1b and Supplementary Fig. 1e),
indicating increased RAS activation. Assessment of the distal
thoracic aorta of 12-week-old, chow-fed KODMAC mice revealed
increased vascular macrophage infiltration (Fig. 1c and Supple-
mentary Fig. 1f, g), as well as increased reactive oxygen species
formation capable of scavenging nitric oxide in the vessel wall,
shown by increased dihydroethidium staining (Fig. 1d), higher
NADPH-mediated detection of ROS (Fig. 1e), and lack of BP
response to the NO synthase inhibitor L-NAME (Fig. 1f). These
events resulted in decreased renal perfusion (Fig. 1g). Lethally
irradiated KODMAC mice transplanted with bone marrow from
other KODMAC (KOD→KOD) or control mice (Con→KOD)
demonstrated that restoration of myeloid VDR could prevent
hypertension, with 20–28 mmHg lower BP (Fig. 1h) and a 36%
reduction in plasma renin (Fig. 1i) after 8 weeks in Con→KOD
mice compared to KOD→KOD mice. Conversely, control mice
transplanted with bone marrow from KODMAC mice KOD→-
Con had an ~18 mmHg increase in BP compared to (Con→Con)
controls (Fig. 1h), with threefold-increased plasma renin (Fig. 1i).
These data demonstrate that loss of myeloid VDR signaling
causes renin-mediated hypertension.
Macrophage miR-106b-5p secretion induces renin production.
Previous studies in spontaneous models of hypertension show
renal interstitial infiltration of macrophages and lymphocytes
prior to the development of hypertension, suggesting that
immune cells may be responsible for hypertension15. Serial
cryosections of KODMAC compared to control littermate kidneys
stained with macrophage-specific antibodies (MOMA) (Fig. 2a) that
were confirmed by flow cytometry (Supplementary Fig. 2a, b)
showed increased macrophages that were adjacent to juxtaglo-
merular (JG) cells (Fig. 2b). To investigate whether JG-localized
macrophages could increase renin production directly, we cocul-
tured KODMAC macrophages with engineered JG cells expressing
YFP under control of the renin promoter (Ren1c-YFP)16,17. Both
KODMAC macrophages and KODMAC media alone were capable
of inducing renin production in JG cells as shown by immuno-
fluorescence (Fig. 2c and Supplementary Fig. 2c), as well as renin
mRNA expression and secretion compared to control (Supple-
mentary Fig. 2d–g), suggesting that a factor secreted from KOD-
MAC macrophages activates JG cells. Previous studies indicate that
locally produced TNFα and IL-1β may play an important paracrine
role in the regulation of the RAS18. While media from unstimulated
KODMAC macrophages had triple the TNFα levels of control
media (Fig. 2d), adding anti-TNFα antibody to KODMAC media
during coculture with JG cells did not significantly reduce renin
production, suggesting an alternate mechanism of RAS stimulation
(Fig. 2e).
Recently, the discovery of circulating extracellular microRNAs
(miRNAs) has suggested a role for miRNAs as intercellular
signaling mediators19. Unbiased miRNA expression analyses
using media from KODMAC or control peritoneal macrophages
identified 361 differentially expressed miRNAs with P < 0.05
(Supplementary Fig. 3a, Supplementary Data 1, NCBI GEO
repository number GSE 155511). We selected 12 upregulated
miRNAs for secondary validation based on prior literature
reports of involvement and/or association with diabetes, hyper-
tension, and endothelial function. We then isolated exosomes,
verified their purity, and confirmed by qPCR that in nine of these
miRNAs, the more abundant product was increased in those from
KODMAC media (Fig. 2f and Supplementary Fig. 3b, c). Of these
nine miRNAs, five were also increased in media of macrophages
from dietary vitamin D-deficient mice compared to vitamin D-
sufficient mice (Fig. 2g), with miR-106b-5p being the most
differentially secreted. To clarify whether any of these macro-
phage miRNAs were increasing JG cell renin production and
release, we transfected Ren1c-YFP JG cells with mimics of the
miRNAs of interest (106b-5p, 340-5p, 193a-3p, 99b-5p, and 325-
3p) or miRNA control. We found that all transfected JG cells had
high mRNA abundance (Supplementary Fig. 4a), but miR-106b-
5p-mimic-transfected cells had fourfold higher renin production
compared to cells transfected with nontargeting control, and had
higher renin production and secretion compared to all other
mimic-transfected cells (Fig. 2h and Supplementary Fig. 4b).
Conversely, transfection of Ren1c-YFP JG cells with miR-106b-5p
antagomir suppressed renin production induced by KODMAC
peritoneal macrophage media, confirming the regulatory role of
miR-106b-5p in JG cell renin production (Fig. 2i). Ren1c-YFP JG
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Fig. 1 Myeloid Vdr deletion induces hypertension by increasing vascular ROS. In 8-week-old KODMAC (light-blue bar) or control mice (white bar): a
invasive mean arterial BP (n= 3/group), b plasma renin (n= 5/group), distal thoracic aortic assessment of (c) MOMA staining (green, DAPI= blue)
(representative of four/group, scale bars: 100 µm), d DHE staining (red, DAPI= blue) in the presence or absence of PEG-superoxide dismutase
(representative of four/group, scale bars: 100 µm), e NADPH-stimulated lucigenin-enhanced chemiluminescence (n= 4/group), f increase in mean arterial
blood pressure (MAP) with L-NAME (n= 5 Con/4 KOD), and g renal cortical blood flow (n= 8/group). Irradiated KODMAC mice transplanted with BM
from KODMAC (KOD→KOD) (light-blue bar) or control (Con→KOD) (yellow bar) and irradiated control mice transplanted with BM from KODMAC
(KOD→Con) (dark-blue bar) or control (Con→Con) (white bar). h Noninvasive BP (n= 24–33/group) and i plasma renin (n= 5/group). Data presented
as mean ± SEM from (a) mixed model analysis, (b–g) Student’s two-tailed unpaired t test with *P < 0.05, ***P < 0.001 vs. control, and (h, i) Student’s two-
tailed unpaired t test with ***P < 0.001 vs. matched donor/recipient control transplant.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18538-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4798 | https://doi.org/10.1038/s41467-020-18538-x | www.nature.com/naturecommunications 3
cells expressed little miR-106b-5p at the baseline, but after
exposure to KODMAC peritoneal macrophages or their media for
72 h, exhibited a fivefold increase in miR-106b-5p abundance
compared to control exposure, suggesting that JG cells take up
secreted macrophage miR-106b-5p (Fig. 2j). To confirm that
macrophage-secreted miR-106b-5p was the source of increased
miR-106b-5p in JG cells, we proactively silenced endogenous
miR-106b in Ren1c-YFP JG cells by transfection with siRNA
against pre-miR-106b, then cocultured these cells with KODMAC
or control macrophage media. KODMAC media exposure
resulted in significantly increased mature miR-106b-5p abun-
dance and renin production in Ren1c-YFP JG cells compared to
cells exposed to control media without induction in pre-miR-
106b-5p expression (Supplementary Fig. 4c and Fig. 2k).
Similarly, KODMAC media increased mature miR-106b-5p
abundance in Ren1c-YFP JG cells transfected with siRNA control
without changes in pre-miR-106b abundance compared to cells
exposed to control media. These data imply that macrophages are
the source of miR-106b-5p. Furthermore, media from peritoneal
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cell miR-106b-5p abundance and renin production compared to
that of vitamin D-sufficient mice (Supplementary Fig. 4d, e),
further demonstrating in a more clinically relevant model a
significant role for vitamin D-deficient macrophage-derived miR-
106b-5p in the stimulation of JG cell renin production.
Macrophage miR-106b-5p knockout prevents hypertension. To
investigate in vivo the role of macrophage miR-106b-5p secretion
in the high blood pressure induced by vitamin D deficiency, miR-
106b−/− and wild-type littermate mice were fed a vitamin D-
deficient or -sufficient chow diet for 10 weeks. As expected, wild-
type mice fed a vitamin D-deficient diet had ~10 mmHg higher
SBP and DBP compared to wild-type vitamin D-sufficient mice.
Importantly, miR-106b knockout prevented the elevation in
blood pressure and plasma renin induced by vitamin D deficiency
(Fig. 3a and Supplementary Fig. 5a). Media from peritoneal
macrophages from vitamin D-deficient miR-106b−/− mice as well
as from vitamin D-sufficient miR-106b+/+ and wild-type litter-
mate mice demonstrated significantly lower activation of JG cell
renin production when compared to macrophage media from
wild-type, vitamin D-deficient littermates (Fig. 3b). Bone marrow
(BM) transplant from miR-106b−/− mice into hypertensive
vitamin D-deficient wild-type mice decreased SBP and DBP and
plasma renin, compared to BM transplant from wild-type mice
(Fig. 3c, d). To confirm the specificity of miR-106b from KOD-
MAC macrophages as the mechanism inducing high BP and JG
cell renin production, we generated double-knockout (KOD-
MAC/miR-106b−/−) mice for comparison to KODMAC/miR-
106+/+ and control Vdr+/+/miR-106+/+ mice and transplanted
their BM into WT mice. We found that the absence of miR-106b
prevented the SBP and DBP elevation, increased plasma renin,
and stimulation of Ren1c-YFP JG renin production by KODMAC
macrophages, suggesting that KODMAC macrophage secretion
of miR-106b-5p increases RAS-dependent hypertension in vivo
(Fig. 3e–g).
Macrophage ER stress causes miR-106b-5p secretion. Previous
studies indicated that vitamin D deficiency or lack of Vdr in
macrophages increases both PERK and IRE phosphorylation, as
well as Chop protein expression by reducing SERCA
function13,20–22. Converging evidence indicates that ER stress
signaling modulates miRNA expression and accelerates exosome
formation and release23,24. Therefore, we hypothesized that
secretion of miR-106-5p by KODMAC macrophages would be
regulated by ER stress. Treatment of vitamin D-deficient mac-
rophages with phenylbutyric acid (PBA, a chemical chaperone
known to reduce ER stress) reduced miR-106b-5p secretion into
the media by more than 65% and decreased media stimulation of
JG cell renin production and secretion (Fig. 3h, i and
Supplementary Fig. 5b). Conversely, induction of macrophage ER
stress by thapsigargin in vitamin D-sufficient control macro-
phages increased miR-106b-5p secretion by 60%, and media from
treated cells increased JG cell renin production and secretion
(Fig. 3j, k and Supplementary Fig. 5c). Since PBA is a nonspecific
inhibitor of ER stress, we obtained mice with knockout of CHOP
(Ddit3) and fed them vitamin D-deficient or -sufficient chow diet
for 10 weeks. Vitamin D deficiency did not increase SBP or DBP
or plasma renin in Ddit3−/− mice (Fig. 3l and Supplementary
Fig. 5d). Moreover, media from vitamin D-deficient peritoneal
macrophages from Ddit3−/− mice as well as from vitamin D-
sufficient Ddit3+/+ and Ddit3−/− mice showed reduced stimu-
lation of JG cell renin production and 60% less miR-106b-5p
secretion compared to vitamin D-deficient Ddit3+/+ macro-
phages (Fig. 3m and Supplementary Fig. 5e). BM transplant from
Ddit3−/− mice into hypertensive vitamin D-deficient Ddit3+/+
mice decreased SBP, DBP, and plasma renin compared to BM
transplant from Ddit3+/+ mice (Fig. 3n, o), confirming that
activation of the ER stress PERK/CHOP pathway by inactivation
of macrophage VDR signaling increases miR-106b-5p secretion
and renin-dependent hypertension.
miR-106b-5p activates PPAR and CREB pathways to induce
renin. Renin transcription is controlled by multiple factors cap-
able of binding to either or both an upstream enhancer and the
proximal promoter region. Among these, peroxisome
proliferator-activated receptor (PPAR) and cAMP-response ele-
ment-binding protein (CREB) family factors have been previously
demonstrated to enhance renin transcription25. Global mRNAs
were assessed by RNA sequencing analysis for response to miR-
106b-5p transfection in JG cells, and renin activators and effectors
were confirmed by qPCR, including upregulation of peroxisome
proliferator-activated receptor gamma coactivator 1-alpha
(Ppargc1a) expression. In addition, protein levels of cAMP-
response element-binding protein (CREB) and its activated form,
phospho-CREB, were also upregulated, despite variation in CREB
family mRNA expression (Fig. 4a and Supplementary Fig. 6). To
search for links between the upregulation of these factors and
mRNAs likely to be directly targeted for suppression by miR-
106b-5p, we performed RISC sequencing from miR-106b-5p-
transfected JG cells and identified 1504 mRNAs for which the
value of the Ago2:polyA-RNA ratio increased by at least 2-fold
upon miR-106-5p transfection, indicating suppression of gene
expression (NCBI GEO repository number GSE11770). Ingenuity
pathways analysis was used to identify mRNAs from this set of
1504, which were also present in an interaction network focused
on Ppargc1a. Of the 18 RISC-enhanced mRNAs present in the
Ppargc1a interaction network, E2f126 and Pde3b27 were deemed
the most likely to result in Ppargc1a upregulation upon their own
suppression. In order to identify mRNAs that would lead to
Fig. 2 KODMAC macrophage miR-106b-5p secretion induces JG cell renin production. a MOMA-positive cells per high-power field (HPF) in the kidney
of KODMAC (light-blue bar) or control mice (white bar) (n= 3/group). b Confocal microscopy of JG apparatus in KODMAC mice with staining for renin
(red), macrophages (green, MOMA-2), and merge (yellow) showing an afferent artery (AA), collecting duct (CD), and glomerulus (GM) (scale bars: 50
µm) (representative of n= 5). c Renin-positive (YFP-labeled Ren1c) JG cells (renin expression= green) cocultured with KODMAC or control macrophages
or their media (forskolin= positive control) (representative of 6/group, scale bars: 50 µm). d Peritoneal macrophage media cytokine secretion from
KODMAC or control mice (n= 8/group). e Renin-positive JG cells after culture with KODMAC macrophage media with or without anti-TNFα antibody (n
= 6/group). Relative miRNA expression from (f) KODMAC or control peritoneal macrophage media exosomes (n= 4/group) and g vitamin D-deficient or
-sufficient peritoneal macrophage media exosomes (n= 4/group). h Renin-positive JG cells after transfection with miRNA mimics (n= 6/group). i Renin-
positive JG cells after transfection with miR-106b-5p antagomir or miR control and exposed to KODMAC macrophage media (n= 6/group). jmiR-106b-5p
abundance in JG cells before and after coculture with KODMAC or control peritoneal macrophages or their media (n= 4/group). k Renin positivity in JG
cells transfected with pre-miR-106b siRNA, then cocultured with KODMAC or control macrophage media (n= 6/group). Data expressed as mean ± SEM
from (a–h, i, k) Student’s two-tailed unpaired t test with **P < 0.01, ***P < 0.001 vs. control or vitamin D-sufficient and j one-way ANOVA with Tukey’s post
hoc test with **P < 0.01, ***P < 0.001.
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enhanced CREB activity when suppressed, we repeated the ana-
lysis with Ingenuity interaction networks focused on adenylate
cyclases. miR-106b-5p increased RISC association, implying
suppression of gene expression, of Pde3b and Pde10a (Fig. 4b),
which hydrolyze cAMP and thus inhibit CREB activity27,28.
Furthermore, E2f1 and Pde3b, but not Pde10a, have miR-106-5p
family-binding sites in both the human and mouse gene 3′UTRs
(Supplementary Fig. 7). Ren1c-YFP JG cells exposed to
KODMAC media had decreased E2F1 and PDE3B protein
expression, increased mRNA expression of Ppargc1a and Pparg,
and increased the levels of cAMP, CREB, and phospho-CREB,
suggesting that media miR-106b-5p is sufficient to repress the
endogenous levels of E2F1 and PDE3B, increasing PPARγ/CREB
stimulation of JG cell renin production (Fig. 4c–e). To validate
that E2f1 and Pde3b downregulation are critical to JG cell renin
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attempt to mimic, at least in part, the likely effect of miR-106b-5p
on increased renin production. Transfection of Ren1c-YFP JG
cells with siRNAs against either E2f1 or Pde3b reduced mRNA
levels (Supplementary Fig. 8) and increased renin production by
approximately fourfold and secretion by more than twofold
(Fig. 4f, g) compared to siRNA control-transfected cells, similarly
to coculture with KODMAC macrophage media. In summary,
impaired vitamin D receptor signaling in macrophages results in
ER stress that increases miR-106b-5p secretion. This miRNA is
taken up by JG cells to activate renin production, identifying a
mechanism of inflammation-induced hypertension (Fig. 4h).
Discussion
We postulate that innate cellular immunity orchestrates the
interaction between metabolic tissues and environmental factors
involved in the development of hypertension. Vitamin D defi-
ciency promotes activation of innate immunity, increasing cyto-
kine production and accelerating vascular infiltration of immune
cells14,29. However, it is unclear whether the pro-inflammatory
changes induced by vitamin D deficiency can accelerate hyper-
tension. Early studies suggested that direct VDR activation in JG
cells repressed renin promoter activation8. In this study, we found
that myeloid-specific VDR deficiency is sufficient to induce high
blood pressure in mice with adequate vitamin D status. In three
different mouse models, we found that deletion of myeloid Vdr
promotes vascular and renal macrophage infiltration and
increases RAS-dependent hypertension. Induction of endo-
plasmic reticulum stress in KODMAC macrophages increases
exosome secretion of miR-106b-5p, which induces JG cell renin
production via repression of transcription factors E2f1 and
Pde3b. Recipients of BM from KODMAC mice experience
increased BP via activation of renal renin production, effects that
are prevented by the knockout of miR-106b-5p in the trans-
planted cells, together confirming a microRNA-dependent mac-
rophage-specific communication with JG cells causing renin-
mediated hypertension.
The role of lymphocytes in the development of hypertension is
well-established; nonetheless, activation or expansion of lym-
phocytes requires activation of the innate immune system30.
Previous studies have shown roles for macrophages in mediating
Ang II-induced or DOCA-salt-induced hypertension15,31, but it is
unknown whether their effects are sufficient to initiate hyper-
tension. Maternal exposure to a low-protein diet induces infil-
tration by immune cells and ROS production in the kidneys of
Sprague–Dawley rat offspring before hypertension develops, and
these events are prevented by early exposure to antioxidants and
immunosuppressive medication32. Moreover, a missense muta-
tion of SH2B adaptor protein 3 in immune cells prevents
infiltration of leukocytes into the kidneys and high-salt-diet-
induced hypertension in the Dahl salt-sensitive rat, further
indicating a potential role of immune cells early in the patho-
genesis of hypertension33. In this study, we discovered that pro-
inflammatory macrophages are capable of inducing hypertension
in nonhypertensive mice. Myeloid Vdr deletion promotes vas-
cular macrophage infiltration, increases ROS-mediated scaven-
ging of NO, and reduces renal perfusion, resulting in increased
plasma renin. Interestingly, deletion of myeloid Vdr also pro-
motes macrophage infiltration into the JG cell apparatus, thereby
regulating JG cell renin production by an unexpected commu-
nication between macrophages and JG cells through miR-106b-
5p. Moreover, knockout of miR-106b-5p prevents the elevation in
BP and stimulation of JG cell renin production by KODMAC
macrophages, suggesting myeloid-specific effects. In diet-induced
vitamin D deficiency, miR-106b deletion prevents vitamin D-
deficiency-induced, renin-dependent hypertension in mice, and
macrophages from such mice are unable to activate JG cell renin
production or release. These findings provide evidence of an
intercellular miRNA communication mechanism enabling mac-
rophages of the innate immune system to induce renin produc-
tion in JG cells and promote hypertension.
Recently, miRNAs have emerged as regulators of vascular
inflammation and RAS-induced hypertension25. Interestingly, in
two different rat hypertensive models, plasma miR-106b expres-
sion robustly increased during the development of hypertension
and concomitant heart failure34. In this study, we provide con-
firmation via multiple mouse models that vitamin D-deficient
macrophages secrete increased miR-106b-5p, which enters into
JG cells and downregulates the transcription-related factors Pde3b
and E2f1, leading to increased renin production and release. A
previous study has shown that the PDE3 inhibitor trequinsin
increases cellular cAMP content and stimulates JG cell renin
release35. The miR-106b-5p-mediated downregulation of PDE3B
and the associated increase in adenylate cyclases, cAMP, and
CREB abundance suggest that cAMP signaling is an important
contributor to miR-106b-5p-induced renin production36. More-
over, deletion of E2f126 or Pde3b27 in mice promotes increased
Ppargc1a, Ppars, and Esrra gene expression in tissues requiring a
high level of energy for normal physiological function; all these
transcription factors are known to increase renin release in JG
cells37,38. These data suggest that miR-106b in JG cells is a global
modulator linking cell signaling pathways to transcription factors
implicated in renin production and release, and may provide an
important target to ameliorate renin-dependent hypertension.
Macrophages display a spectrum of phenotypes including
“M1” and “M2” in response to different stimuli, and miRNA
expression profiles may reflect these macrophage phenotypes39,40.
Fig. 3 Macrophage ER stress regulates miR-106-5p secretion and BP. In dietary vitamin D-deficient or -sufficient miR-106b−/− or littermates: a
noninvasive BP (n= 10/group) and b renin-positive (YFP-labeled Ren1c) JG cells (n= 3/group) after culture with macrophage media. In vitamin D-deficient
(light- and dark-blue bars) or -sufficient control mice (white and green bars) transplanted with BM from miR-106b–/– or control mice on matched diet: c
noninvasive BP (n= 12 recip/group) and d plasma renin (n= 5 recip/group). In wild-type recipients transplanted with BM from KODMAC/miR-106b−/−
(light-blue bar), KODMAC/miR-106+/+ (dark-blue bar), or control Vdr+/+/miR-106+/+ mice (white bar): e noninvasive BP (n= 6/group), f plasma renin
(n= 6/group), and g renin-positive JG cells after culture with macrophage media (n= 3/group). In JG cells cocultured with media from vitamin D-deficient
peritoneal macrophages treated with (dark-blue bar) or without phenylbutyric acid (PBA) (light-blue bar): h miR-106b-5p abundance and i renin-positive
cells (n= 6/group). In JG cells cocultured with media from vitamin D-sufficient peritoneal macrophages treated with (green bar) or without thapsigargin
(white bar): j miR-106b-5p abundance and k renin-positive cells (n= 6/group). In Ddit3+/+ or Ddit3−/− mice fed vitamin D-deficient and -sufficient diets: l
noninvasive BP (n= 8–11/group), m renin-positive JG cells after coculture with their peritoneal macrophage media (n= 3/group). In vitamin D-deficient
(light- and dark-blue bars) or -sufficient control mice (white and green bars) transplanted with BM from Ddit3−/– or control mice on matched diet: n
noninvasive BP (n= 6 recip/group) and o plasma renin activity (n= 6 recip/group). Data expressed as mean ± SEM from (a, b, e–g, l,m) one-way ANOVA
with Tukey’s post hoc test with ***P < 0.001 vs. all, (c, d, n, o) Student’s two-tailed unpaired t test with *P < 0.05, **P < 0.01, ***P < 0.001 vs. matched
donor/recipient diet, and (h–k) Student’s two-tailed unpaired t test with *P < 0.05, **P < 0.01, ***P < 0.001 vs. vitamin D-deficient or -sufficient macrophage
control media.
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However, the mechanism(s) that regulates altered macrophage
miRNA secretion are unknown. We previously demonstrated that
regulation of ER stress by vitamin D in type 2 diabetes exerts a
pivotal role in monocyte recruitment, macrophage phenotype,
and cholesterol metabolism, and regulates critical components of
the vascular remodeling seen in diabetic vascular disease13,21,22. A
recent study indicated that ER stress activation in HeLa cells
increased multivesicular body formation and exosome release by
the ER stress transducers IRE1 and PERK, suggesting that ER
stress not only regulates exosome release, but might also change
miRNA secretion profiles24. In this study, we found that activa-
tion of macrophage PERK-unfolded protein response by Vdr
deletion promotes miR-106-5p exosome release and causes JG cell
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global deletion of the ER stress chaperone Ddit3 (CHOP) pre-
vents vitamin D-deficiency-induced renin-dependent hyperten-
sion in mice, and their macrophages are unable to activate JG cell
renin production. These data indicate a critical role of the mac-
rophage pPERK/CHOP-unfolded protein response in regulating
inflammation-associated metabolic diseases.
Our findings provide evidence that dysregulated macrophage
signaling in response to vitamin D deficiency is sufficient to cause
hypertension by a microRNA-specific mechanism that enables
communication from innate immune cells to JG cells. A detailed
understanding of the mechanisms by which macrophage ER
stress causes miR-106b-5p secretion will direct the development
of specific therapies preventing the miRNA-mediated activation
of multiple signaling pathways and transcription factors involved
in renin-dependent hypertension.
Methods
Experimental models. Mice with inactivation of VDR in myeloid cells (KnockOut
of vitamin D receptor in MACrophages: KODMAC) were generated and used for
assessment of blood pressure and macrophage–JG cell interactions. Briefly, Vdrfl/fl
mice were crossed with mice expressing transgenic Cre recombinase under control
of the Lyzosomal M promoter (Lyz2Cre+/−)(Jax/Lab 004781) in the Ldlr−/− (Jax/
Lab 002207) background as well as in C57BL6/J (Jax/Lab 000664) and Apoe−/−
(Jax/Lab 002052) backgrounds13. Littermate mice with Lyz2Cre−/–Vdrfl/fl in the
corresponding background were used as controls. To evaluate the role of macro-
phage miR-106b secretion and/or ER stress on vitamin D-deficiency-induced
hypertension, we also studied miR-106b–/− (Jax/Lab 008460) and Ddit3−/– (Jax/
Lab 030816) mice compared to C57BL6/J littermates. Vitamin D-sufficient and
-deficient mice were generated by feeding standard chow (Harlan TD7022) or
vitamin D-deficient chow diet with 2% calcium (Harlan TD87095), respectively, for
8 weeks prior to assessment. 25-hydroxyvitamin D levels in the dietary vitamin D-
deficient models were as follows (deficient vs. sufficient, respectively): 9.4 ± 1.7 vs.
51 ± 2.8 in C57, 48 ± 4 vs. 47 ± 2.1 in KODMAC, 7.6 ± 0.7 vs. 44 ± 6 in miR-
106b–/−, and 13 ± 1 vs. 51 ± 2.3 in Ddit3−/−. To generate the KODMAC/miR-
106−/− double knockout, we first crossed Vdrfl/flCre+/– with miR-106b–/– mice
until we obtained Vdrfl/flCre+/–/miR-106−/−, Vdrfl/flCre+/–/miR-106b+/+, or
control Vdr+/+/miR-106b+/+ mice, all in the C57BL6 45.2 background. Specific
Vdr deletion was verified13. Then, we transplanted their BM into C57BL6 45.1
recipients and characterized their phenotype 8 weeks post transplant. Mice were
housed in a clean facility with an ambient temperature of 65–75 °F, 40–60%
humidity, and 12 light/12 dark cycles. All experiments included male and female
animals. Protocols followed were approved by the Washington University Insti-
tutional Animal Care and Use Committee and compliant with ethical regulations
for studies involving laboratory animals.
Bone marrow (BM) transplantation. BM cells were isolated from the femurs and
tibias of 8–10-week-old mice by flushing the bones with cold PBS13. The total bone
marrow was washed, triturated using a 24-gauge needle (Benson Dickson), col-
lected by centrifugation at 200 × g for 4 min, and diluted with PBS. After lysis of
erythrocytes using 0.05% sodium azide, cells were counted to obtain a defined
concentration of unfractionated bone marrow. Eight-week-old recipient mice were
lethally irradiated with 10 Gy from a cesium-137 γ-cell irradiator. Within 6 h after
irradiation, recipients were reconstituted with ~5 × 106 donor marrow cells via a
single injection. The donor marrow was allowed to repopulate for 8 weeks after
transplantation prior to assessment. For estimating engraftment, the total bone
marrow was isolated from the femurs and tibias from C57BL/6-TgN (GFP-posi-
tive) (Jax/Lab 003291) mice in the same background in parallel for each transplant
experiment. FACS quantification of the percentage of GFP positivity in peripheral
leukocytes revealed engraftment of 85–92%. In BM recipients of KODMAC/miR-
106b−/− or KODMAC/miR-106b+/+, the degree of engraftment was performed by
using C57BL6 45.2 donors and 45.1 recipients to confirm engraftment in the
experimental animals (CD45.1 and CD45.2 antibodies, Biolegend, Inc). Flow-
cytometry quantification of the percentage of 45.2 positivity in peripheral leuko-
cytes or recipients revealed engraftment of 88–96%, implying reduction in Vdr or
miR-106b expression to 4–12% of baseline.
Vascular physiological assessment. Systolic and diastolic blood-pressure mea-
surements were measured in conscious mice 8 weeks after weaning using the
CODA-2 noninvasive tail cuff measurement system. Mice of both genders were
acclimated to handling and placement in the apparatus daily for 2 days before the
measurement of blood pressure. Multiple measurements were made at each of
three daily sessions and averaged to obtain a single value for each mouse41.
Twenty-four-hour invasive blood-pressure monitoring in conscious mice was
performed using the PA-C10 telemetry sensor by the Data Science International
System. Mouse BP recording was completed a week after the sensor implantation.
Blood-pressure data obtained were averaged every 30 min for 24 h, including the
mouse light and dark cycles42. Vascular O2.− formation was measured by the
lucigenin-enhanced chemiluminescence assay. Mouse thoracic aortas were
removed, placed into prewarmed Krebs–Henseleit/HEPES buffer, and cut into 3-
mm ring segments. Segments were transferred to a white 96-well microplate
containing Krebs–Henseleit/HEPES buffer (100 μL) with lucigenin (10 μmol/L; this
low concentration prevents autooxidation). NADPH (100 μmol/L) was added to
each well after 10 min. Chemiluminescence was recorded every 2 min in a
microplate luminometer at 37 °C (Lucy-1, Rosys Anthos). The vessels were dried
(24 h at 90 °C) and weighed. The results are expressed as counts per minute per
milligram dry tissue43. Vascular responses to inhibition of nitric oxide synthase
were recorded invasively (PowerLab/8SP, AD Instruments) after the intravenous
infusion of 5 mg kg−1 L-NAME42. Renal blood flow was performed under iso-
flurane anesthesia, using a renal flow probe (0.5PSB Nanoprobe with handle,
Transonic) in 8-week-old mice44 after volume repletion with 8 μl/g body weight of
normal saline, followed by 0.5 μl/min/g.
Immunofluorescence. Kidneys and aortas were harvested, and 10-μm cryosections
from distal aorta and kidney were fixed for 24 h in 10% formalin and blocked with
goat antiserum. Then, they were incubated with primary MOMA-2 rat monoclonal
antibody dilution 5 μg/ml (Abcam #ab33451), and/or anti-renin45 overnight, then
with secondary antibody. DAPI (Vector Laboratories) mounting was used for
counterstaining. Images were captured on a confocal microscope (Olympus
Fv1000)29. Vascular and renal macrophages were quantified by flow cytometry
using two different macrophage markers (CD11b and F4/80)46,47. To perform
tissue flow cytometry, we extracted mouse aortas (heart to the iliac bifurcation) and
decapsulated kidneys and minced into 2–4-mm pieces using scissors or scalpel
blade. Both tissues were mixed with collagenase media on a rotary tube suspension
mixer at 37 °C for 20 min and then mechanically digested using a 1000-μL pipette
tip. Disperse cells were filtered through a cell strainer and collected in 10 mL of
Flow Cytometry Staining Buffer. A single-cell suspension was generated by
pressing with the plunger of a 3-mL syringe. Cells were then centrifuged at
300–400 × g for 4–5 min at 2–8 °C. The cell pellet was resuspended in flow cyto-
metry staining buffer. A final cell concentration of 1 × 107 cells/mL was incubated
with 0.2 mg/mL of C11b-PE (eBioscience™ #12-0112-81) and F4/80-PECy7
(eBioscience™ 25-4801-82) antibodies for 15 min on ice, then washed, and flow
cytometry was performed. Cell aggregates, dead, and cellular debris were excluded
based on FSC/SCC. Batch analysis by FlowJo version 9.6.2 was used for gating
consistency, and select positive population. We used unstained samples and
blocking with FC to decrease autofluorescence and unspecific background. Cells
were stained with two macrophage antibodies for anti-CD11b PE and F4/80 PE-
Cyanine7 F4/80. Rat IgG2b K (eBioscience™ #12-4031-82) and IgG2a K
(eBioscience™ #25-4321-82) isotype control for anti-CD11b PE and F4/80 PE-
Cyanine7, respectively, to ensure antibody-specific detection. The oxidative fluor-
escent probe dihydroethidium (DHE) and confocal microscopy were used to detect
Fig. 4 Enhancement of renin transcription by miR-106b-5p modulation of PPAR and CREB signaling. a Pppargc1a mRNA expression and CREB (n= 5/
group) and phospho-CREB protein abundance in miR-106b- (light-blue bar), or control- (white bar) transfected JG cells (n= 6/group). b Histogram
displaying frequencies of log2 Ago2-IP vs. global polyA(RNA) abundance ratio for all detected mRNAs (gray bars) with positions of selected PPAR and
CREB signaling mediators under control (green) and miR-106b-transfected (purple) conditions. c E2f1, Pde3b, CREB, and phospho-CREB protein expression
in JG cells exposed to control (white bar) or KODMAC media (light-blue bar) (representative of 4/group). d Pppargc1a and Pparg mRNA expression (n=
4/group), and cAMP and CREB protein abundance in JG cells after culture with KODMAC or control peritoneal macrophage media (n= 6/group). e
Schematic diagram of relevant cell signaling pathways. Macrophage miR-106b-5p inhibits JG cell E2f1 and Pde3b, removing inhibition of PCG1 and CREB
pathways to induce renin production. Blue arrows represent stimulatory pathways and red lines represent inhibitory pathways, while X represents
repressed inhibition. f Renin-positive (YFP-labeled Ren1c) JG cells and g renin secretion after transfection with siRNAs against E2f1 (yellow bar) or Pde3b
(green bar) or coculture with KODMAC macrophage media (light-blue bar) (n= 6/group). h Mechanistic schematic diagram. Data expressed as mean ±
SEM from (a, d) Student’s two-tailed unpaired t test with *P < 0.05, ***P < 0.001 vs. control and (f, g) one-way ANOVA with Tukey’s post hoc test with **P
< 0.001 vs. all.
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in situ levels of ROS in aorta sections. Ten-micron unfixed frozen sections were
used for DHE visualization with adjacent sections analyzed by DAPI to detect all
mural nuclei. To confirm that DHE fluorescence reflects ROS levels, sections from
aortae were preincubated for 30 min with superoxide dismutase–polyethylene
glycol (10 mmol/L) before incubation with DHE. Images were digitally captured by
fluorescence microscopy as described48. In the kidney, MOMA-positive macro-
phages were quantified by the percentage of the total renal area. Images were
acquired by an observer blinded to the treatment groups.
Peritoneal macrophages and juxtaglomerular (JG) cells. Murine peritoneal
macrophages were collected immediately following injection of PBS into the
peritoneum13,29. Macrophages were cultured in DMEM plus 10% FBS for 3 h prior
to assessment. Ren1c-YFP JG cells were cultured in DMEM/F12 media with 10%
exosome-depleted FBS17. Cells were seeded at 0.1 × 106 cells/well in 12-well plates
and grown to 80–90% confluence, estimated to be a maximum of 0.5 × 106 cells/
well. Transwell chambers were utilized (Costar polycarbonate filters, 3-µm pore
size). Membranes and 12-well plates were coated with fibronectin (5 µg/mL, Life
Technologies) overnight at 4 °C13. Macrophages (0.3 × 105 cells/well) were added to
the upper chamber, or directly over the Ren1c-YFP JG cells cultivated in the lower
chamber. Cells were incubated for 72 h, and quantification of renin production was
performed using computer-based quantification using Image J to identify YFP-
positive JG cells across different samples. We binarized our images to decrease low-
intensity objects, and used an erode filter to remove objects smaller than a cell. We
generated black-and-white images for DAPI and YFP channels, counted the cells
that were positive for both channels, quantified the number of cells positive for
DAPI, or both YFP and DAPI, and expressed as a percentage of all DAPI-positive
cells. Macrophage media and JG cells were additionally incubated with 0.2 µg/ml
TNFα-neutralizing antibody on 1 µg/mL dilution (R&D Biosystems #MAB4101)
for 72 h, and quantification of renin-producing cells was evaluated as described
above. Reduction of ER stress was obtained by adding a chemical chaperone,
phenylbutyric acid (PBA, 20 mmol/L, Calbiochem, San Diego, CA) to peritoneal
vitamin D-deficient macrophages for 18 h prior to coculture. Induction of ER stress
was obtained by adding thapsigargin (0.25 nmol/L, Sigma) to peritoneal macro-
phages from vitamin D-sufficient mice for 18 h prior to coculture. YFP-labeled
Ren1c-JG cells were cocultured for 72 h with media from PBA-treated vitamin D-
deficient or thapsigargin-treated vitamin D-sufficient macrophages21.
Metabolic assays. Renin was measured in plasma samples pooled from groups of
five animals by mouse renin-1 ELISA kit from Sigma-Aldrich (#RAB0565). TNF-α
(BD Biosciences) and IL-1β (R&D Biosystems) concentrations were measured by
ELISA in coculture media13. Urine Na sample was obtained by a bladder catheter
after volume repletion with 8 μl/g body weight of normal saline, followed by 0.5 μl/
min/g and analyzed by electrolyte analyzer (Roche). Total and phosphorylated
CREB abundance was measured by magnetic bead-based immunoassay (Bio-Rad
Bio-Plex #171V60013M and #171304006M). cAMP level was measured by ELISA
(Invitrogen #EMSCAMPL).
MicroRNA array. RNA was extracted from cell culture supernatants (macrophage
media), processed, and hybridized to Affymetrix GeneChip miRNA 4.0 micro-
arrays by Washington University’s Genome Technology Access Center. Post-
processing of array signal data was performed with Partek Genomics Suite 6.6
(Partek, St Louis, MO).
Exosome isolation. We isolated exosome vesicles from media from macrophages
alone and from macrophage coculture with YFP-labeled Ren1c-JG cells using
ultracentrifugation. Following 72 h of coculture, media was collected, then cen-
trifuged at 2000 × g for 30 min to remove cells and debris. The supernatant was
then transferred to a new tube without disturbing the pellet. The media was then
centrifuged at 100,000 × g for 18 h. Density-gradient-based isolation was then
performed to obtain purer exosome preparations using the Total Exosome Isola-
tion kit (Invitrogen)49,50. The degree of purity of the isolated exosome vesicles was
confirmed by western blot of 0.5 μg of protein per lane showing the presence of EV
marker protein expression from categories 1a and 1b [Invitrogen CD63 (#PA5-
92370), CD81 (#MA5-32333), and CD9 (#MA5-31980)] and category 2a [Invi-
trogen Alix (#PA5-52873)] and the absence of non-EV protein expression from
category 3a [Invitrogen albumin (#PA5-89332)]50,51.
MicroRNA and mRNA expression via RT-qPCR. miRNA purification and iso-
lation from Ren1c-YFP JG cells was performed using the mirVana miRNA kit
(Invitrogen Ambion) and anti-miR (Life Technologies #AM10067). RTq-PCR was
performed using the TaqMan reagent kit, with relative expression of miRNA cal-
culated by the comparative threshold cycle method relative to miR-U6 in cell tissue
as an internal control. For assays from culture media, we spiked in miR-39 from C.
elegans as an exogenous housekeeping miRNA control prior to extraction (Qiagen
#219610). Relative expression of miRNA was calculated by the comparative
threshold cycle method relative to miR-39 abundance. TaqMan primers were
obtained from Life Technologies for miRNAs 17-5p (#002308), 17-3p (#002543),
106b-5p (#000442), 106b-3p (#002380), 26a-5p (#000405), 26a-3p (#002443),
146a-5p (#000468), 146a-3p (#463191), 195a-5p (#000494), 195a-3p (#002107),
103-5p (#121218), 103 3p (#000439), 99b-5p (#000436), 99b-3p (#002196), 107-5p
(#465082), 107-3p (#000443), 155-5p (#002571), 155-3p (#464539), 151-5p
(#002642), 151-3p (#001190), 340-5p (#002258), 340-3p (#002259), 191-5p
(#002299), 191-5p (#002576), 130b-5p (#002460), 130b-3p (#00456), 92a-5p
(#002496), 92a-3p (#00430), U6 (#4427975,) and 39 (#467942). For mRNA RTq-
PCR, total RNA (1 μg) was treated with DNase and reverse-transcribed using
Superscript II (Invitrogen) with oligo-dT as the primer. PCR was performed with
the GeneAmp 7000 Sequence Detection System using the SYBR® Green reagent kit
(Applied Biosystems). RNA not subjected to reverse transcription was included in
each assay as negative control. We used the following mouse oligonucleotides: for
Pparg forward 5′-AGCCTCATGAAGAGCCTTCCA-3′, Pparg reverse 5′-
TCCGGAAGAAACCCTTGCA-3′; Ppargc1 forward 5′-AGCCTCTTTGCCCA-
GATCTT-3′, Ppargc1 reverse 5′-GGCAATCCGTCTTCATCCAC-3′; Ren1 forward
5′-TTACGTTGTGAACTGTAGCCA-3′, Ren1 reverse 5′-AGTATGCA-
CAGGTCATCGTTC-3′; Pde3b forward 5′-GGTGATGGTGGTGAAGAA-3′,
Pde3b reverse 5′-AGTGAGGTGGTGCATTAG-3′; E2F1 forward 5’-
ACTCCTCGCAGATCGTCATCATCT-3′, E2f1 reverse 5′-GGACGTTGGT-
GATGTCATAGATGCG-3′; Mrpl32 forward, 5’-AAGCGAAACTGGCGGAAAC-
3′,Mrpl32 reverse, 5′-GATCTGGCCCTTGAACCTTCT-3′. All assays were done in
triplicate. Data are expressed as relative expression of mRNA normalized to mouse
ribosomal protein Mrpl32.
Plasmids and small-interfering RNA transfection. Ren1c-YFP JG cells were
transfected withmirVana miR-106b mimic (Life Technologies #4464066) and miR-
106b antagomir (Life Technologies #AM10067), and 72 h after transfection, mRNA
expression in JG cell lysates was evaluated with RT-qPCR, and JG cell renin
production was evaluated with confocal microscopy (Olympus Fv1000). Ren1c-YFP
JG cells were transduced with lentivirus containing sense in Pde3b-siRNA, E2f1-
siRNA, or control siRNA for 48 h (Life Technologies #s71385, #65234, and
#4390843, respectively)20. Protein expression for PDE3B (Abcam AB #95814,
dilution 1 μg/mL), E2F1 (Abcam #112580, dilution 1 μg/mL), CREB-1 (Santa Cruz
#SC377154, dilution 5 μg/mL), and phospho-CREB-1 (Ser133, Cell Signalling
#9198, dilution 1 μg/mL) was performed in JG cells exposed to 72 h of KODMAC
or control media. Renin mRNA expression and renin production were determined
72 h after recovery from transfection or viral transduction. Also, Ren1c-YFP JG
cells were transfected with pri-miR-106b-5p siRNA sense oligonucleotides 5′-CCU
AAU GAC CCU CAA GCC GUU-3′ and antisense 5′-CGG CUU GAG GGU CAU
UAG GUU-3′, then exposed to KODMAC macrophage media for 72 h, and miR-
106 pre-miR or mature miR-106b mRNA was assessed.
RNA-seq and RISC-seq methods. Transcriptomic profiling of individual JG cell
samples was performed using RNA sequencing beginning with 1 mg of total RNA
isolated using Trizol (Life Technologies) exactly according to the manufacturer’s
directions as initial input for mRNA-Seq, or with Ago2-immunoprecipitated
material from 150-mm-diameter dishes for RISC-Seq. For mRNA-seq, polyA RNA
enrichment was performed using Dynabeads mRNA Purification Kit (Life Tech-
nologies, Carlsbad, CA, USA). Ago2 immunoprecipitation was performed in ice-
cold 50 mM Tris–HCl, 5 mM EDTA, 5 mM EGTA, pH 7.5, with 0.5% Nonidet P-
40, Roche Complete protease inhibitors, and yeast tRNA and SUPERnase-IN added
to final concentrations of 1 μg/μL and 1 U/μL52. polyA-RNA and Ago2-
immunoprecipitated RNA was fragmented using a fragmentation buffer (40 mM
Tris acetate, 100 mMK acetate, and 30 mMMg acetate, pH 8.2; 2 min for 30 s at 95
°C). First-strand cDNA was generated using the Superscript III 1st Strand Synthesis
System (Life Technologies) and the second strand was generated using 10 U DNA
Polymerase I (New England Biolabs, Ipswich, MA, USA), 40 U E. coli DNA Ligase
(New England Biolabs), and 2 U RNase H (Life Technologies) in 20 mM Tris.HCl,
pH 6.9, 66 μM dNTPs, 90 mM KCl, 4.6 mMMgCl2, 0.15 mM b-NAD+, and 10 mM
(NH4)2SO4 at 16 °C for 2 h. Finally, Illumina sequencing libraries were prepared
using End-It DNA End Repair Kit (Epicentre, Madison, WI, USA) and Klenow
Fragment (30/50 exo-) (New England Biolabs) for the ligation of Illumina
sequencing adapters (Illumina-Index-AdapterA and 5’-phosphorylated Illumina-
Index-AdapterB) using the Liga-Fast™ Rapid DNA Ligation System (Promega,
Madison, WI, USA). Fragments between 150 and 300 bp were recovered after 2%
agarose gel electrophoresis in order to remove adapter dimers by size selection
(QIAquick Gel Extraction Kit, Qiagen). Nucleotide indexes to permit sample
deconvolution were added to individual libraries using Phusion DNA polymerase
(New England Biolabs) during 16 cycles of amplification. Samples were quantitated
(Nanodrop, Thermo Scientific, Wilmington, DE, USA), mixed, and submitted for
sequencing on a HiSeq 3000 instrument (Illumina Inc., San Diego, CA, USA) at
Washington University GTAC to obtain single-end, 50-bp reads. After removal of
mouse ribosomal RNA reads using a custom procedure, the remaining reads were
aligned to the Illumina iGenomes GRCm38 Ensembl release of the mouse tran-
scriptome using Tophat2 version 2.1.153. An average of 5.2 × 106 aligned reads
were obtained per sequencing library and quantitated at the gene level using HTSeq
version 0.9.154. mRNAs were included in downstream analyses if present in at least
three of four biological replicates in any experimental group (polyA control, polyA
miR-106b, Ago2-IP control, and Ago2-IP miR-106b) at an abundance of at least 1
read per million. A total of 15,365 mRNAs were obtained from this filtering
procedure. Pairwise comparisons between experimental groups were made using
the robust dispersion modification of edgeR version 1.2.455.
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Statitical analysis. Experiments were carried out in duplicate or triplicate. The
number of samples in each experiment (n) refers to the number of distinct samples.
Gaussian distribution of continuous variables was verified by
Kolmogorov–Smirnov distance. Parametric data are expressed as the mean ± SEM
and analyzed by two-sided t tests, paired or unpaired as appropriate, or by one-way
ANOVA and Tukey’s post test for more than two groups. Nonparametric data are
presented as the median and analyzed using the Mann–Whitney test. Differences
were considered statistically significant if P ≤ 0.05. Statistical analysis was carried
out using GraphPad Prism version 8.4.3.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Noncoding RNA-profiling array data, as well as RNA sequences from JG cells and RISC
sequence data have been deposited in the NCBI GEO repository with accession numbers
GSE 155511 and GSE117704, respectively. Source data are provided with this paper.
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